Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Roche Unlock the Potential of Locked Nucleic AcidsHear more from leading author and scientific expert, Dr Bo Rode Hansen at RNA Therapeutics 2017
By: SMi Group The established event set to take place on 22nd & 23rd February 2017 in Central London, will once again gather a global audience of scientific leaders, KOL's and drug development specialists, providing a focal point to discuss the future of targeted drug delivery. Respected for his extensive RNA experience and involvement in the Locked Nucleic Acid drug platform, Dr Bo Rode Hansen has authored and co-authored over 40 peer reviewed publications. He is currently the Global Head of RNA Therapeutics Research at Roche and General Manager of the Roche Innovation Centre in Copenhagen. His presentation will provide new insights into RNA therapeutics drug discovery discussing key updates surrounding: Dr Bo Rode Hansen will be joining other notable speakers in the field at RNA Therapeutics 2017 including: John Johnston, Clinical Assessor Biologicals & Biotechnology Unit, MHRA Jeffrey Ulmer, Head Preclinical Research and Development, GSK Vaccines US Sanyogitta Puri, Associate Principal Scientist, AstraZeneca Nagy Habib, Head of Surgery, Co-Founder, Imperial College Healthcare NHS Trust, MiNA Therapeutics Heinrich Haas, Vice President RNA Formulation & Drug Delivery, BioNTech RNA Pharmaceuticals Nicole Meisner-Kober, Senior Investigator, RNA Biology, Novartis Institutes for Biomedical Research David Giljohann, CEO, Exicure Shai Erlich, Chief Medical Officer & President USA, Quark Pharmaceuticals Inc Amotz Shemi, CEO, Silenseed A detailed agenda and full speaker line-up is available at http://www.smi- --- end --- Contact Information: For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk To register for the conference, visit http://www.smi- To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|